Dr. Molina joined Cougar as Senior Vice President, Clinical Research and Development, in May 2007. He brings to Cougar over 20 years of clinical investigation and drug development experience in oncology, encompassing both the biotechnology industry and academic settings. From 2002 until joining Cougar, Dr. Molina held a number of positions at Biogen Idec, most recently serving as Senior Director and Acting Head of the Oncology/Hematology therapeutic area in the Department of Medical Research and Clinical Development. In that role, Dr. Molina was responsible for all in-house and co-developed clinical stage hematology and oncology drug candidates. Prior to Biogen Idec, Dr. Molina was a faculty staff physician and an Adjunct Professor at City of Hope Comprehensive Cancer Center where he held numerous positions in the Division of Hematology and Bone Marrow Transplantation and the Division of Medical Oncology and Therapeutics Research. Dr. Molina also served on the Board of Directors of City of Hope Medical Group and was President-Elect of City of Hope Medical Staff.
A graduate of Stanford University School of Medicine, Dr. Molina also received an M.S. degree in Physiology and completed his post-graduate residency training in Internal Medicine and fellowships in Medical Oncology, Biological Sciences and Bone Marrow Transplantation at Stanford |